Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

SHEL LAB Introduces the Bactrox Chamber

Published: Tuesday, May 15, 2012
Last Updated: Monday, May 14, 2012
Bookmark and Share
Ideal for low oxygen conditions in microaerophilic bacteriology, tissue & cell culture applications.

Sheldon Manufacturing, Inc. has introduced the SHEL LAB Bactrox Chamber, the latest addition to its industry leading Bactron line of anaerobic chambers. The Bactrox offers precise oxygen and carbon dioxide control from 1-20%.

The SHEL LAB Bactrox Chamber (http://www.shellab.com/store/lab-products/Bactrox) preserves optimal application conditions not only during incubation but also in the chamber work station.

Removal of cultures from the incubator does not require exposure of cells to undesirable oxygen or carbon dioxide levels.

The unit’s advanced atmospheric controller allows for the use of a highly accurate and long-lasting zirconium dioxide oxygen sensor, with independent oxygen and carbon dioxide control and logging.

The Bactrox also has a standalone 300 plate incubator so users can comfortably work without gloves in ambient room conditions.

“It is exciting to bring this type of technology to our Bactron line. Most importantly, it broadens the scope of research that can be performed by our customers,” states Dan Sheldon, President of Sheldon Manufacturing, Inc.

To minimize set-up time, the Bactrox includes an extra- large vacuum-less sample pass box that takes only sixty seconds to purge. The new design provides a vacuum-less sleeve entry into the chamber.

Other features of this unit include temperature control and logging, superior condensation control, and ultra bright LED examination lights inside the chamber.

The Bactrox is ideal for stem cell research, mammalian cancer research and clinical and research microbiology, and joins the SHEL LAB line of Bactron Anaerobic Chambers (http://www.shellab.com/store/categories/1-bactron-chambers/) including the BacBASIC, and Bactron I, II, III and IV.

The Bactrox is available through SHEL LAB distribution partners.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Nanosensors Could Determine Tumours’ Ability to Remodel Tissue
Researchers design nanosensors that can profile tumours, focusing on protease levels.
1960s Antibiotics Show Promise for TB Therapy
Research suggests antibiotics introduced in 1963 to treat bacterial infections show promise for tuberculosis therapy.
Insight into Eye Diseases
Scientists recreate zebrafish cell regeneration from retinal stem cells in mice.
Analysing 10,000 Cells Simultaneously
New techniquethat traps 10,000 cells on a single chip has potential for cancer screening for individuals.
Studies Explore the Science of Cardiovascular Diseases
Two studies highlight how basic science research insights are key to future treatment breakthroughs.
Stem Cell ‘Heart Patch’ Almost Perfected
Scientists aiming to perfect and test 3D "heart patches" in animal model, last hurdle before human patients.
Using Stem Cells to Grow a 3D Lung-in-a-Dish
Researchers have created 3D lung-like tissue from lung-derived stem cells. The tissue can be used to study lung diseases.
MRI Guidance Aids Stem Cell Delivery
Scientists have delivered stem cells to the brain with unprecedented precision, infusing the cells under real-time MRI guidance.
Mechanisms of Parkinson’s Pathology
Defects that lead to cells’ failure to decommission faulty mitochondria cause nerve cells to die, triggering the symptoms of Parkinson’s disease.
Advanced Lymphoma in Remission After T-Cell Therapy
63% of trial participants who recieved two-drug combination chemo plus intermediate dose of engineered T cells went into complete remission.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!